Sentiment-Signal
3,8
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (26.03.2026)
HOCH Abgang Schlüsselpersonen (13.02.2026)
HOCH Abgang Schlüsselpersonen (26.03.2026)
HOCH Abgang Schlüsselpersonen (13.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 26.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer |
| 13.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ¨ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoin |
| 13.01.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer |
| 07.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ons) with respect to Ms. Peacock reportable under Item 5.02(d) of Form 8-K and Item 404(a) of Regulation S-K since the b |
| 14.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ¨ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoin |
| 12.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ¨ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoin |
| 12.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 07.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | a) of the Exchange Act. ¨ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of C |
Stammdaten
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Unternehmen & Branche
| Name | IDEXX LABORATORIES INC /DE |
|---|---|
| Ticker | IDXX |
| CIK | 0000874716 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 2835 · In Vitro & In Vivo Diagnostic Substances |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 43,64 Mrd. USD |
| Beta | 1,72 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 4,303,702,000 | 1,059,464,000 | 13.08 | 3,350,759,000 | 1,605,383,000 |
| 2025-09-30 | 10-Q | 1,105,239,000 | 274,610,000 | 3.40 | 3,386,712,000 | 1,561,186,000 |
| 2025-06-30 | 10-Q | 1,109,457,000 | 293,989,000 | 3.63 | 3,330,794,000 | 1,458,827,000 |
| 2025-03-31 | 10-Q | 998,427,000 | 242,677,000 | 2.96 | 3,213,689,000 | 1,448,013,000 |
| 2024-12-31 | 10-K | 3,897,504,000 | 887,867,000 | 10.67 | 3,293,443,000 | 1,595,313,000 |
| 2024-09-30 | 10-Q | 975,543,000 | 232,841,000 | 2.80 | 3,350,766,000 | 1,618,054,000 |
| 2024-06-30 | 10-Q | 1,003,578,000 | 203,298,000 | 2.44 | 3,414,867,000 | 1,580,253,000 |
| 2024-03-31 | 10-Q | 964,095,000 | 235,579,000 | 2.81 | 3,353,515,000 | 1,568,906,000 |
| 2023-12-31 | 10-K | 3,660,953,000 | 845,042,000 | 10.06 | 3,259,925,000 | 1,484,530,000 |
| 2023-09-30 | 10-Q | 915,527,000 | 212,231,000 | 2.53 | 3,086,404,000 | 1,297,407,000 |
| 2023-06-30 | 10-Q | 943,630,000 | 224,236,000 | 2.67 | 2,870,806,000 | 1,093,861,000 |
| 2023-03-31 | 10-Q | 900,195,000 | 214,054,000 | 2.55 | 2,808,398,000 | 841,101,000 |
| 2022-12-31 | 10-K | 3,367,324,000 | 679,089,000 | 8.03 | 2,746,765,000 | 608,737,000 |
| 2022-09-30 | 10-Q | 841,661,000 | 180,938,000 | 2.15 | 2,640,067,000 | 475,999,000 |
| 2022-06-30 | 10-Q | 860,546,000 | 131,979,000 | 1.56 | 2,607,185,000 | 457,008,000 |
| 2022-03-31 | 10-Q | 836,549,000 | 193,965,000 | 2.27 | 2,592,689,000 | 639,798,000 |
| 2021-12-31 | 10-K | 3,215,360,000 | 744,845,000 | 8.60 | 2,437,203,000 | 689,992,000 |
| 2021-09-30 | 10-Q | 810,421,000 | 175,235,000 | 2.03 | 2,385,744,000 | 754,754,000 |
| 2021-06-30 | 10-Q | 826,142,000 | 202,582,000 | 2.34 | 2,412,149,000 | 747,460,000 |
| 2021-03-31 | 10-Q | 777,707,000 | 204,257,000 | 2.35 | 2,327,385,000 | 702,696,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -1,758 | 634.57 | -1,115,577.22 | -90,5% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -3,660 | 658.92 | -2,411,634.76 | -195,7% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -2,860 | 657.84 | -1,881,433.27 | -152,6% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -2,859 | 659.75 | -1,886,223.82 | -153,0% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -2,589 | 663.04 | -1,716,620.66 | -139,3% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,669 | 652.49 | -1,089,013.32 | -88,4% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,488 | 655.85 | -975,904.50 | -79,2% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,343 | 656.85 | -882,142.97 | -71,6% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,281 | 650.67 | -833,507.63 | -67,6% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,200 | 661.10 | -793,317.12 | -64,4% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,171 | 653.68 | -765,454.95 | -62,1% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,111 | 654.63 | -727,293.26 | -59,0% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,095 | 651.49 | -713,377.83 | -57,9% | |
| 2026-02-26 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -2,693 | 661.54 | -1,781,530.72 | -144,5% | |
| 2026-02-26 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,000 | 662.16 | -662,156.70 | -53,7% | |
| 2026-02-17 | Erickson Michael G | Officer, Executive Vice President | Open Market Sale | -204 | 625.24 | -127,549.43 | -10,3% | |
| 2026-02-17 | Vandebroek Sophie V. | Director | Open Market Sale | -945 | 628.65 | -594,070.47 | -48,2% | |
| 2026-02-17 | Vandebroek Sophie V. | Director | Open Market Sale | -519 | 628.56 | -326,222.64 | -26,5% | |
| 2026-02-17 | Erickson Michael G | Officer, Executive Vice President | Open Market Sale | -2,694 | 628.22 | -1,692,426.84 | -137,3% | |
| 2026-02-17 | Erickson Michael G | Officer, Executive Vice President | Open Market Sale | -1,288 | 626.26 | -806,618.24 | -65,4% | |
| 2026-02-17 | Erickson Michael G | Officer, Executive Vice President | Open Market Sale | -689 | 629.09 | -433,443.42 | -35,2% | |
| 2026-02-17 | Erickson Michael G | Officer, Executive Vice President | Open Market Sale | -456 | 623.76 | -284,433.74 | -23,1% | |
| 2026-02-17 | Erickson Michael G | Officer, Executive Vice President | Open Market Sale | -40 | 629.86 | -25,194.50 | -2,0% | |
| 2026-02-10 | FENNELL GEORGE | Officer, Executive Vice President | Open Market Sale | -397 | 644.02 | -255,674.35 | -20,7% | |
| 2026-02-10 | FENNELL GEORGE | Officer, Executive Vice President | Open Market Sale | -40 | 650.32 | -26,012.80 | -2,1% | |
| 2026-02-10 | FENNELL GEORGE | Officer, Executive Vice President | Open Market Sale | -966 | 648.78 | -626,720.71 | -50,8% | |
| 2026-02-10 | FENNELL GEORGE | Officer, Executive Vice President | Open Market Sale | -1,060 | 647.21 | -686,039.00 | -55,7% | |
| 2026-02-10 | FENNELL GEORGE | Officer, Executive Vice President | Open Market Sale | -1,130 | 643.00 | -726,587.06 | -58,9% | |
| 2026-02-10 | FENNELL GEORGE | Officer, Executive Vice President | Open Market Sale | -2,161 | 645.25 | -1,394,387.84 | -113,1% | |
| 2026-02-10 | FENNELL GEORGE | Officer, Executive Vice President | Open Market Sale | -2,782 | 646.23 | -1,797,800.45 | -145,9% | |
| 2026-02-10 | FENNELL GEORGE | Officer, Executive Vice President | Open Market Sale | -2,809 | 649.26 | -1,823,771.06 | -148,0% | |
| 2025-11-07 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -1,378 | 705.54 | -972,240.73 | -78,9% | |
| 2025-11-07 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -5,114 | 702.20 | -3,591,059.49 | -291,3% | |
| 2025-11-07 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -1,468 | 704.87 | -1,034,743.14 | -83,9% | |
| 2025-11-07 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -1,465 | 703.73 | -1,030,970.16 | -83,6% | |
| 2025-08-22 | SZOSTAK M ANNE | Director | Open Market Sale | -2,187 | 647.33 | -1,415,700.21 | -114,9% | |
| 2025-08-12 | Erickson Michael G | Officer, Executive Vice President | Open Market Sale | -318 | 649.99 | -206,696.82 | -16,8% | |
| 2025-08-12 | Erickson Michael G | Officer, Executive Vice President | Open Market Sale | -88 | 649.85 | -57,116.68 | -4,6% | |
| 2025-08-11 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -1,200 | 656.53 | -787,840.20 | -63,9% | |
| 2025-08-08 | Underberg Sharon E. | Officer, EVP, GC & Corporate Secretary | Open Market Sale | -5,450 | 651.60 | -3,551,220.00 | -288,1% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -3,397 | 629.82 | -2,139,508.05 | -173,6% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -3,000 | 632.56 | -1,897,689.00 | -154,0% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,822 | 636.15 | -1,159,068.40 | -94,0% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,525 | 628.27 | -958,114.80 | -77,7% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -1,095 | 626.90 | -686,458.13 | -55,7% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -880 | 636.81 | -560,391.30 | -45,5% | |
| 2025-08-06 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -3,018 | 629.87 | -1,900,932.57 | -154,2% | |
| 2025-08-06 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -2,907 | 630.91 | -1,834,051.59 | -148,8% | |
| 2025-08-06 | Hunt Nimrata | Officer, Executive Vice President | Open Market Sale | -1,218 | 630.69 | -768,179.32 | -62,3% | |
| 2025-08-06 | Lane Michael | Officer, Executive Vice President | Open Market Sale | -5,631 | 627.56 | -3,533,809.51 | -286,7% | |
| 2025-08-06 | Lane Michael | Officer, Executive Vice President | Open Market Sale | -2,480 | 627.99 | -1,557,417.93 | -126,4% | |
| 2025-08-06 | Lane Michael | Officer, Executive Vice President | Open Market Sale | -300 | 628.89 | -188,665.98 | -15,3% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -7,299 | 631.61 | -4,610,095.84 | -374,0% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -6,056 | 630.59 | -3,818,874.24 | -309,8% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -3,526 | 635.13 | -2,239,457.10 | -181,7% | |
| 2025-08-06 | MAZELSKY JONATHAN JAY | Director, Officer, President and CEO | Open Market Sale | -660 | 639.37 | -421,985.39 | -34,2% | |
| 2025-05-21 | SZOSTAK M ANNE | Director | Open Market Sale | -1,046 | 513.74 | -537,372.04 | -43,6% | |
| 2025-05-21 | SZOSTAK M ANNE | Director | Open Market Sale | -1,260 | 512.34 | -645,544.75 | -52,4% | |
| 2025-05-13 | JUNIUS DANIEL M | Director | Open Market Sale | -2,683 | 506.41 | -1,358,697.23 | -110,2% | |
| 2025-05-09 | Vandebroek Sophie V. | Director | Open Market Sale | -1,279 | 491.34 | -628,425.27 | -51,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.